샘플 요청 목록

 카트 문의
시장보고서
상품코드
1985974

미국의 유방 생검 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품 종류별, 시술 종류별, 유도 기술별, 최종 용도별, 지역별, 부문별 예측(2026-2033년)

U.S. Breast Biopsy Devices Market Size, Share & Trends Analysis Report By Product Type, By Procedure Type, By Guidance Technology, By End Use, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 110 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 2,950 금액 안내 화살표 ￦ 4,390,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 3,950 금액 안내 화살표 ￦ 5,878,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 5,950 금액 안내 화살표 ￦ 8,854,000
카드담기
※ 부가세 별도
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

미국의 유방 생검 기기 시장 요약

미국의 유방 생검 기기 시장 규모는 2025년에 11억 8,000만 달러로 추정되며, 2033년까지 16억 달러에 달할 것으로 예측되며, 2026년부터 2033년까지 CAGR 3.9%로 성장할 것으로 전망됩니다.

이 시장의 성장은 유방암 발병률의 증가와 이에 따른 조기 발견 및 정확한 진단에 대한 중요성 인식에 힘입어 이루어지고 있으며, 이로 인해 선별 검사 및 진단 과정에서 필요한 생검 시술 건수가 증가하고 있습니다.

체계적인 스크리닝 프로그램 및 유리한 보험 환급 환경에 힘입어 환자와 임상의들 사이에서 높은 인지도를 바탕으로 기기 도입에 더욱 박차를 가하고 있습니다. 또한, 최소침습적 코어 니들 및 진공 보조 시스템, 첨단 영상 진단(초음파, MRI, 3D 유방촬영술 등)과의 통합, AI를 활용한 진단 워크플로우와 같은 기술 발전으로 임상적 유용성이 확대되고, 시술의 정확성과 환자 편의성이 향상되어 보다 폭넓은 임상 통합이 촉진되고 있습니다.

미국 내 유방암 유병률의 증가는 유방 생검 장비 시장의 성장을 직접적으로 견인하고 있습니다. 이는 신규 및 암 의심 환자 수가 증가함에 따라 조직 채취를 통한 진단 확정에 대한 수요가 증가하기 때문입니다. 미국에서 유방암은 여성에서 가장 많이 진단되는 암으로, 매년 수십만 건의 침습성 및 비침습성 유방암이 보고되고 있습니다. 이로 인해 영상 검사에서 이상 소견이 발견되면 정기적인 검진 및 추적 생검이 증가하고 있습니다. 발병률의 증가와 검진 프로그램의 확대에 따라 의료진은 진단 확정, 치료 방침 결정, 악성 종양 제거를 위해 더 많은 생검을 시행하고 있으며, 그 결과 코어 니들 생검, 진공 보조 생검 및 영상 유도 유방 생검 장비의 사용이 촉진되고 있습니다.

유방촬영술, MRI 등 검진 프로그램이 확대됨에 따라 더 많은 의심스러운 병변이 발견되어 코어침 생검이나 진공보조생검을 통한 조직 채취가 필요하게 되었습니다. 이러한 진단 건수의 지속적인 증가로 병원 및 외래 진료 센터의 첨단 영상 유도하 생검 시스템에 대한 수요가 증가하고 있습니다. 사례 발견 수의 증가와 기기 혁신의 연관성은 최근 업계 동향에서도 확인할 수 있습니다. 예를 들어, 2026년 2월 다나허 코퍼레이션 산하 맘모톰(Mammotome)은 생검 중 MRI 스캐너실에서 환자 옆에 설치할 수 있도록 설계된 최초의 시스템인 'Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System'을 발표했습니다. 이러한 혁신은 MRI 유도하 검사에서 의료진의 협업과 워크플로우의 효율성을 향상시킴으로써 유방암 유병률 증가로 인한 검사 부담 증가에 대응하고, 미국 내 유방암 생검 장비 분야의 기술 도입과 시장 성장을 가속화하고 있습니다.

자주 묻는 질문

  • 미국의 유방 생검 기기 시장 규모는 어떻게 예측되나요?
  • 유방 생검 기기 시장의 성장은 어떤 요인에 의해 이루어지고 있나요?
  • 유방 생검 기기 시장에서 기술 발전은 어떤 영향을 미치고 있나요?
  • 미국 내 유방암 유병률의 증가는 유방 생검 장비 시장에 어떤 영향을 미치고 있나요?
  • 유방 생검 기기 시장에서 최근의 혁신 사례는 무엇인가요?

목차

제1장 분석 방법·범위

제2장 주요 요약

제3장 미국의 유방 생검 기기 시장 : 변수, 동향, 범위

제4장 미국의 유방 생검 기기 시장 : 제품별 추정·동향 분석

제5장 미국의 유방 생검 기기 시장 : 시술 종류별 추정·동향 분석

제6장 미국의 유방 생검 기기 시장 : 유도 기술별 추정·동향 분석

제7장 미국의 유방 생검 기기 시장 : 최종 용도별 추정·동향 분석

제8장 경쟁 구도

KSM 26.04.24

U.S. Breast Biopsy Devices Market Summary

The U.S. breast biopsy devices market size was estimated at USD 1.18 billion in 2025 and is anticipated to reach USD 1.60 billion by 2033, growing at a CAGR of 3.9% from 2026 to 2033. The market growth driven by the rising incidence of breast cancer and the consequent emphasis on early detection and accurate diagnosis, which increases the volume of biopsy procedures required in screening and diagnostic pathways.

High awareness among patients and clinicians, supported by structured screening programs and favorable reimbursement landscapes, further propels device adoption. In addition, technological advancements, including minimally invasive core-needle and vacuum-assisted systems, integration with advanced imaging modalities (e.g., ultrasound, MRI, 3D mammography), and AI-enhanced diagnostic workflows, are expanding clinical utility, improving procedural accuracy and patient comfort, and encouraging broader clinical integration.

The rising prevalence of breast cancer in the U.S. directly drives growth in the breast biopsy devices market because a higher number of new and suspected cancer cases increases the demand for diagnostic confirmation through tissue sampling. In the U.S., breast cancer is the most commonly diagnosed cancer among women, with hundreds of thousands of new invasive and non-invasive cases reported annually, prompting more routine screening and follow-up biopsies when abnormalities are detected on imaging. As incidence rates climb and screening programs expand, healthcare providers perform more biopsies to confirm diagnoses, guide treatment decisions, and rule out malignancy, thereby boosting utilization of core-needle, vacuum-assisted, and image-guided breast biopsy devices.

As screening programs such as mammography and MRI expand, more suspicious lesions are detected, necessitating tissue sampling via core-needle or vacuum-assisted biopsy. This sustained rise in diagnostic volumes increases demand for advanced, image-guided biopsy systems in hospitals and ambulatory centers. The link between higher case detection and device innovation is evident in recent industry developments, for instance, in February 2026, Mammotome, a part of Danaher Corporation, introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System, the first system designed to be positioned inside the MRI scanner room at the patient's side during biopsy. By improving clinician coordination and workflow efficiency in MRI-guided procedures, such innovations address the growing procedural burden driven by rising breast cancer prevalence, thereby accelerating technology adoption and overall market growth in the U.S. breast biopsy devices sector.

U.S. Breast Biopsy Devices Market Report Segmentation

This report forecasts revenue growth at the country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the U.S. breast biopsy devices market report based on product, procedure type, guidance technology, and end use:

  • Product Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopsy Guidance Systems
    • Biopsy Drivers & Handpieces
    • Vacuum-Assisted Biopsy (VAB) Drivers
  • Core Needle Biopsy (CNB) Guns
    • Automated
    • Semi-Automated
  • Biopsy Tables
    • Prone Tables
    • Upright/Add-on Tables
  • Biopsy Consumables
    • Needles & Probes
    • Site Markers & Clips
    • By Shape/Design
    • Standard Geometric Markers
    • Ring
    • Cross
    • Ribbon
    • Others
    • Advanced Anchoring Markers
    • Anchor
    • Wing, "U" Shape
    • Q" Shape
    • 3D / Expandable Markers
    • 3D Ribbon
    • 3D Sphere
    • 3D Mesh
    • Localization Systems
    • Traditional Wires
    • Wireless Seeds-RFID/Magnetic
  • Other Consumables
  • Procedure Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Vacuum-Assisted Biopsy (VAB)
  • Core Needle Biopsy (CNB)
  • Fine Needle Aspiration Biopsy (FNAB)
  • Surgical (Open) Biopsy
  • Liquid Biopsy
  • Guidance Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Ultrasound-Guided
  • Mammography / Stereotactic-Guided
  • MRI-Guided
  • End Use Outlook (Revenue, USD Million; 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialized Breast Care Centers
  • Diagnostic Centers/Imaging Centers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product
    • 1.1.2. Procedure Type
    • 1.1.3. Guidance Technology
    • 1.1.4. End Use
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Breast Biopsy Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Increasing burden of breast cancer
      • 3.2.1.2. Expansion of breast cancer screening programs
      • 3.2.1.3. Technological advancements in imaging-guided biopsy
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of advanced biopsy technologies
      • 3.2.2.2. Limited access to diagnostic facilities in low-resource settings
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Expansion of screening programs in emerging economies
      • 3.2.3.2. Growth of minimally invasive and rapid diagnostic technologies
      • 3.2.3.3. Integration with next-generation imaging and AI
      • 3.2.3.4. Expansion of outpatient and ambulatory care
      • 3.2.3.5. Rising demand for personalized and precision diagnostics
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Patient anxiety and procedure hesitation
      • 3.2.4.2. Limited skilled workforce
  • 3.3. U.S. Breast Biopsy Devices Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. U.S. Breast Biopsy Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Breast Biopsy Devices Market: Product Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. U.S. Breast Biopsy Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
    • 4.3.1. Biopsy Guidance Systems
      • 4.3.1.1. Biopsy guidance systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Biopsy Drivers & Handpieces
      • 4.3.2.1. Biopsy drivers & handpieces market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.2. Vacuum-assisted biopsy (VAB) drivers
        • 4.3.2.2.1. Vacuum-assisted biopsy (VAB) drivers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3. Core needle biopsy (CNB) guns
        • 4.3.2.3.1. Core needle biopsy (CNB) guns market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.3.2. Automated
          • 4.3.2.3.2.1. Automated market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.2.3.3. Semi-automated
          • 4.3.2.3.3.1. Semi-automated market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Biopsy tables
      • 4.3.3.1. Biopsy tables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.2. Prone tables
        • 4.3.3.2.1. Prone tables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.3.3. Upright/add-on tables
        • 4.3.3.3.1. Upright/add-on tables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Biopsy consumables
      • 4.3.4.1. Biopsy consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.2. Needles & probes
        • 4.3.4.2.1. Needles & probes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.3. Site markers & clips
        • 4.3.4.3.1. Site markers & clips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.2. By shape/design
          • 4.3.4.3.2.1. By shape/design market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.3. Standard geometric markers
          • 4.3.4.3.3.1. Standard geometric markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.3.2. Ring
            • 4.3.4.3.3.2.1. Ring market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.3.3. Cross
            • 4.3.4.3.3.3.1. Cross market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.3.4. Ribbon
            • 4.3.4.3.3.4.1. Ribbon market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.3.5. Others
            • 4.3.4.3.3.5.1. Others markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.4. Advanced anchoring markers
          • 4.3.4.3.4.1. Advanced anchoring markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.4.2. Anchor
            • 4.3.4.3.4.2.1. Anchor markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.4.3. Wing, "U" shape
            • 4.3.4.3.4.3.1. Wing, "U" shape market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.4.4. "Q" shape
            • 4.3.4.3.4.4.1. "Q" shape markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.3.5. 3D / expandable markers
          • 4.3.4.3.5.1. 3D / expandable markers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.5.2. 3D ribbon
            • 4.3.4.3.5.2.1. 3D ribbon market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.5.3. 3D sphere
            • 4.3.4.3.5.3.1. 3D Sphere market revenue estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.3.4.3.5.4. 3D Mesh
            • 4.3.4.3.5.4.1. 3D Mesh market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.3.4.4. Localization systems
        • 4.3.4.4.1. Localization systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.4.2. Traditional wires
          • 4.3.4.4.2.1. Traditional wires market revenue estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.3.4.4.3. Wireless Seeds-RFID/magnetic
          • 4.3.4.4.3.1. Wireless seeds-RFID/magnetic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.5. Other Consumables
      • 4.3.5.1. Other consumables market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Breast Biopsy Devices Market: Procedure Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Breast Biopsy Devices Market: Procedure Type Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. U.S. Breast Biopsy Devices Market Size & Trend Analysis, by Procedure Type, 2021 to 2033 (USD Million)
    • 5.3.1. Vacuum-Assisted Biopsy (VAB)
      • 5.3.1.1. Vacuum-assisted biopsy (VAB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Core Needle Biopsy (CNB)
      • 5.3.2.1. Core needle biopsy (CNB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.3. Fine Needle Aspiration Biopsy (FNAB)
      • 5.3.3.1. Fine needle aspiration biopsy (FNAB) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.4. Surgical (Open) Biopsy
      • 5.3.4.1. Surgical (open) biopsy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.5. Liquid Biopsy
      • 5.3.5.1. Liquid biopsy market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Breast Biopsy Devices Market: Guidance Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Breast Biopsy Devices Market: Guidance Technology Movement Analysis, 2025 & 2033 (USD Million)
  • 6.3. U.S. Breast Biopsy Devices Market Size & Trend Analysis, by Guidance Technology, 2021 to 2033 (USD Million)
    • 6.3.1. Ultrasound-Guided
      • 6.3.1.1. Ultrasound-guided market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Mammography / Stereotactic-Guided
      • 6.3.2.1. Mammography / stereotactic-guided market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. MRI-Guided
      • 6.3.3.1. MRI-guided market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Breast Biopsy Devices Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Breast Biopsy Devices Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
  • 7.3. U.S. Breast Biopsy Devices Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
    • 7.3.1. Hospitals
      • 7.3.1.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Ambulatory Surgical Centers (ASCs)
      • 7.3.2.1. Ambulatory surgical centers (ASCs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Specialized Breast Care Centers
      • 7.3.3.1. Specialized breast care centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Diagnostic Centers/Imaging Centers
      • 7.3.4.1. Diagnostic centers/imaging centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis, 2025
  • 8.4. Company Heat Map Analysis
  • 8.5. Strategy Mapping
    • 8.5.1. Expansion
    • 8.5.2. Mergers & Acquisition
    • 8.5.3. Partnerships & Collaborations
    • 8.5.4. New Product Launches
    • 8.5.5. Research And Development
    • 8.5.6. Company Profiles
    • 8.5.7. Hologic, Inc.
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Mammotome (Danaher)
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. BD
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Argon Medical
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Merit Medical Systems
      • 8.5.11.1. Company overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. GE HealthCare
      • 8.5.12.1. Company overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Cook Medical
      • 8.5.13.1. Company overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. MOLLI Surgical (Stryker)
      • 8.5.14.1. Company overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic initiatives
    • 8.5.15. Planmed Oy
      • 8.5.15.1. Company overview
      • 8.5.15.2. Financial performance
      • 8.5.15.3. Product Benchmarking
      • 8.5.15.4. Strategic initiatives
    • 8.5.16. Siemens Healthineers
      • 8.5.16.1. Company overview
      • 8.5.16.2. Financial performance
      • 8.5.16.3. Product Benchmarking
      • 8.5.16.4. Strategic initiatives
    • 8.5.17. Fujifilm Healthcare
      • 8.5.17.1. Company overview
      • 8.5.17.2. Financial performance
      • 8.5.17.3. Product Benchmarking
      • 8.5.17.4. Strategic initiatives
    • 8.5.18. INRAD
      • 8.5.18.1. Company overview
      • 8.5.18.2. Financial performance
      • 8.5.18.3. Product Benchmarking
      • 8.5.18.4. Strategic initiatives
    • 8.5.19. Resitu Medical
      • 8.5.19.1. Company overview
      • 8.5.19.2. Financial performance
      • 8.5.19.3. Product Benchmarking
      • 8.5.19.4. Strategic initiatives
    • 8.5.20. TransMed7, LLC.
      • 8.5.20.1. Company overview
      • 8.5.20.2. Financial performance
      • 8.5.20.3. Product Benchmarking
      • 8.5.20.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제